These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 15894067)

  • 41. Behavioral methods in cannabinoid research.
    Fride E; Perchuk A; Hall FS; Uhl GR; Onaivi ES
    Methods Mol Med; 2006; 123():269-90. PubMed ID: 16506414
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neurons on cannabinoids: dead or alive?
    Guzman M
    Br J Pharmacol; 2003 Oct; 140(3):439-40. PubMed ID: 14522839
    [No Abstract]   [Full Text] [Related]  

  • 43. Pharmaco-toxicological effects of the novel third-generation fluorinate synthetic cannabinoids, 5F-ADBINACA, AB-FUBINACA, and STS-135 in mice. In vitro and in vivo studies.
    Canazza I; Ossato A; Vincenzi F; Gregori A; Di Rosa F; Nigro F; Rimessi A; Pinton P; Varani K; Borea PA; Marti M
    Hum Psychopharmacol; 2017 May; 32(3):. PubMed ID: 28597570
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Behavioral evidence for the interaction of oleamide with multiple neurotransmitter systems.
    Fedorova I; Hashimoto A; Fecik RA; Hedrick MP; Hanus LO; Boger DL; Rice KC; Basile AS
    J Pharmacol Exp Ther; 2001 Oct; 299(1):332-42. PubMed ID: 11561096
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Low brain penetrant CB1 receptor agonists for the treatment of neuropathic pain.
    Adam JM; Clark JK; Davies K; Everett K; Fields R; Francis S; Jeremiah F; Kiyoi T; Maidment M; Morrison A; Ratcliffe P; Prosser A; Schulz J; Wishart G; Baker J; Boyce S; Campbell R; Cottney JE; Deehan M; Martin I
    Bioorg Med Chem Lett; 2012 Apr; 22(8):2932-7. PubMed ID: 22421020
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Motor dysfunction produced by tacrine administration in rats.
    Carriero DL; Outslay G; Mayorga AJ; Aberman J; Gianutsos G; Salamone JD
    Pharmacol Biochem Behav; 1997 Dec; 58(4):851-8. PubMed ID: 9408186
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Structure-activity relationships in cannabinoids.
    Razdan RK
    Pharmacol Rev; 1986 Jun; 38(2):75-149. PubMed ID: 3018800
    [No Abstract]   [Full Text] [Related]  

  • 48. Activation of cannabinoid type 1 receptors decreases the synchronization of local field potential oscillations in the hippocampus and entorhinal cortex and prolongs the interresponse time during a differential-reinforcement-of-low-rate task.
    Liao WT; Chang CL; Hsiao YT
    Eur J Neurosci; 2020 Nov; 52(10):4249-4266. PubMed ID: 32510690
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Targeting mediodorsal thalamic CB1 receptors to inhibit dextromethorphan-induced anxiety/exploratory-related behaviors in rats: The post-weaning effect of exercise and enriched environment on adulthood anxiety.
    Banaei-Boroujeni G; Rezayof A; Alijanpour S; Nazari-Serenjeh F
    J Psychiatr Res; 2023 Jan; 157():212-222. PubMed ID: 36495603
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The role of fluorine substitution in the structure-activity relationships (SAR) of classical cannabinoids.
    Crocker PJ; Mahadevan A; Wiley JL; Martin BR; Razdan RK
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1504-7. PubMed ID: 17257842
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cb1 receptor-mediated signaling emerges as a novel lead to evidence-based treatment development for stress-related psychopathology.
    Bailey CR; Neumeister A
    Neurosci Lett; 2011 Sep; 502(1):1-4. PubMed ID: 21787837
    [No Abstract]   [Full Text] [Related]  

  • 52. Impact of At Least 2 Years of Synthetic Cannabinoid Use on Cognitive and Psychomotor Functions Among Treatment-Seeking Male Outpatients.
    Umut G; Evren C; Atagun MI; Hisim O; Yilmaz Cengel H; Bozkurt M; Keskinkilic C
    Cannabis Cannabinoid Res; 2020 Jun; 5(2):164-171. PubMed ID: 32656348
    [No Abstract]   [Full Text] [Related]  

  • 53. Effort-related motivational effects of the pro-inflammatory cytokine interleukin-6: pharmacological and neurochemical characterization.
    Yohn SE; Arif Y; Haley A; Tripodi G; Baqi Y; Müller CE; Miguel NS; Correa M; Salamone JD
    Psychopharmacology (Berl); 2016 Oct; 233(19-20):3575-86. PubMed ID: 27497935
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A high efficacy cannabinergic ligand (AM4054) used as a discriminative stimulus: Generalization to other adamantyl analogs and Δ(9)-THC in rats.
    Järbe TU; LeMay BJ; Thakur GA; Makriyannis A
    Pharmacol Biochem Behav; 2016 Sep; 148():46-52. PubMed ID: 27264437
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CB1 antagonism produces behaviors more consistent with satiety than reduced reward value in food-maintained responding in rats.
    Thompson EE; Jagielo-Miller JE; Vemuri VK; Makriyannis A; McLaughlin PJ
    J Psychopharmacol; 2016 May; 30(5):482-91. PubMed ID: 27005309
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications.
    Castaneto MS; Gorelick DA; Desrosiers NA; Hartman RL; Pirard S; Huestis MA
    Drug Alcohol Depend; 2014 Nov; 144():12-41. PubMed ID: 25220897
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effort-related motivational effects of the pro-inflammatory cytokine interleukin 1-beta: studies with the concurrent fixed ratio 5/ chow feeding choice task.
    Nunes EJ; Randall PA; Estrada A; Epling B; Hart EE; Lee CA; Baqi Y; Müller CE; Correa M; Salamone JD
    Psychopharmacology (Berl); 2014 Feb; 231(4):727-36. PubMed ID: 24136220
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of a novel CB1 agonist on visual attention in male rats: role of strategy and expectancy in task accuracy.
    Miller RL; Thakur GA; Stewart WN; Bow JP; Bajaj S; Makriyannis A; McLaughlin PJ
    Exp Clin Psychopharmacol; 2013 Oct; 21(5):416-25. PubMed ID: 24099361
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis and characterization of 2-substituted bornane pharmacophores for novel cannabinergic ligands.
    Duclos RI; Lu D; Guo J; Makriyannis A
    Tetrahedron Lett; 2008 Sep; 49(39):5587-5589. PubMed ID: 23935221
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.